Evaluation of minimum inhibitory and minimum bactericidal concentration of nano-silver base inorganic anti-microbial agent (Novaron®) against streptococcus mutans

Contemporary Clinical Dentistry

Volumn 3, Issue 3, 2012, Pages 288-293

  Holla, Goda ^a   Yeluri, Ramakrishna ^a   Munshi, Autar Krishen ^a  

^a Kanti Devi Dental College and Hospital   (India)

Author keywords

Broth dilution assay; MBC; MIC; novaron ; S. Mutans; silver supported anti microbial agent

Indexed keywords

EID: 84918822897     PISSN: 0976237X     EISSN: 09762361     Source Type: Journal    
DOI: 10.4103/0976-237X.103620     Document Type: Article

References (60)

1. Fitzgerald RJ, Keyes PH. Demonstration of the etiologic role of streptococci in test caries in the hamster. J Am Dent Assoc 1960;61:9-19.
2. Svanberg M, Mjor IA, Orstavik D. Mutans streptococci in plaque from margins of amalgam, composite and glass ionomer restorations. J Dent Res 1990;69:861-4.
3. Quiryen M, Bollen CM. The influence of surface roughness and surface-free energy on supra and subgingival plaque formation in man. A review of the literature. J Clin Periodontol 1995;22:1-14.
4. Skjorland KK. Bacterial accumulation on silicate and composite materials. J Biol Buccale 1976;4:315-22.
5. Weitman RT, Eames WB. Plaque accumulation on composite surfaces after various finishing procedures. J Am Dent Assoc 1975;81:101-6.
6. Yap AU, Khor E, Foo SH. Fluoride release and antibacterial properties of new generation tooth coloured restoratives. Oper Dent 1999;24:297-305.
7. Cooley RL, McCourt JW. Fluoride-releasing removable appliances. Quintessence Int 1991;22:299-302.
8. Forsten L. Fluoride release from a glass ionomer cement. Scand J Dent Res 1977;85:503-4.
9. Tveit AB, Gjerdet NR. Fluoride release from a fluoride-containing amalgam, a glass ionomer cement and a silicate cement in artificial saliva. J Oral Rehabil 1981;8:237-41.
10. Banks PA, Burn A, O'Brien K. A clinical evaluation of the effectiveness of including fluoride into an orthodontic bonding adhesive. Eur J Orthod 1997;19:391-5.
11. Brett DW. A discussion of silver as an antimicrobial agent: Alleviating the confusion. Ostomy Wound Manage 2006;52:34-41.
12. Russell AD, Hugo WB. Antimicrobial activity and action of silver. Prog Med Chem 1994;31:351-70.
13. Stickler DJ. Biomaterials to prevent nosocomial infections: Is silver the gold standard? Curr Opin Infect Dis 2000;13:389-93.
14. Williams RL, Doherty PJ, Vince DG, Grashoff GJ, Williams DF. The biocompatibility of silver. Crit Rev Biocompat 1989;5:221-43.
15. Bragg PD, Rainnie DJ. The effect of silver ions on the respiratory chain of Escherichia coli. Can J Microbiol 1973;20:883-9.
16. Morrier JJ, Suchett - Kaye G, Nguyen D, Rocca JP, Blanc-Benon J, Barsotti O. Antimicrobial activity of amalgams, alloys and their elements and phases. Dent Mater 1998;14:150-7.
17. Yee R, Holmgren C, Mulder J, Lama D, Walker D, van Palenstein Helderman W. Efficacy of silver diamine flouride for arresting caries treatment. J Dent Res 2009;88:644-7.
18. Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv 2009;27:76-83.
19. Holister P, Weener JW, Romas Vas C, Harper T. Nanoparticles: Technology white papers 3, London: Sientific Ltd; 2003. p. 2-11.
20. Thomas V, Sreedhar MM, Bajpai SK, Sreedhar B. Fabrication, characterization of chitosan/nanosilver film and its potential antibacterial application. J Biomater Sci Polym Edn. 2009;20:2129-44.
21. Novaron®. Available from: http://www.hsingnan.com.tw/NOVARON.pdf [Last accessed on 2011 Dec 28.
22. She WJ, Zhang FQ. Comparison of the antibacterial activity on oral pathogens among six types of nano-silver base inorganic antibacterial agents. Shanghai Kou Qiang Yi Xue 2003;12:356-8.
23. Zhang FQ, She WJ, Fu YF. Comparison of the cytotoxicity in vitro among six types of nano-silver base inorganic antibacterial agents. Zhonghua Kou Qiang Yi Xue Za Zhi 2005;40:504-7.
24. Tanagawa M, Yoshida K, Matsumoto S, Yamada T, Atsuta M. Inhibitory effect of antibacterial resin composite against streptococcus mutans. Caries Res 1999;33:366-71.
25. Miles AA, Misra SS, Irwin JO. Estimation of the bactericidal power of the blood. J Hyg (Lond) 1938;38:732-49.
26. Bratthall D, Carlsson P. Clinical microbiology of saliva. In: Tenuovo JO. Human saliva: Clinical, chemistry and microbiology. Boca Raton: CRC Press; 1989. p. 204-23.
27. Leal SC, Mickenautsch S. Salivary streptococcus mutans count and caries outcome - a systematic review. J Minim Interv Dent 2010;3:139-45.
28. Humberto HL, Ayala-Nunez NV, Liliana del Carmen IT, Cristina RP. Bactericidal effect of silver nanoparticles against multidrug-resistant bacteria. World J Microbiol Biotechnol 2010;26:615-21.
29. Ribeiro I, Ericson D. In vitro antibacterial effect of chlorhexidine added to glassionomer cements. Scand J Dent Res 1991;99:533-40.
30. Jedrychowski JR, Caputo AA, Kerper S. Antibacterial and mechanical properties of restorative materials combined with chlorhexidines. J Oral Rehabil 1983;10:373-81.
31. Imazato S, Torii M, Tsuchitani Y. Antibacterial effect of composite incorporating triclosan against S. mutans. J Osaka Univ Dent She 1995;35:5-11.
32. Al-Musallam TA, Evans CA, Drummond JL, Matasa CG, Wu CD. Antimicrobial properties of an orthodontic adhesive combined with cetylpyridinium chloride. Am J Orthod Dentofacial Orthop 2006;129:245-51.
33. Stobie N, Duffy B, McCormack DE, Colreavy J, Hidalgo M, McHale P, et al. Prevention of Staphylococcus epidermidis biofilm formation using a low-temperature processed silver-doped phenyltriethoxysilane sol-gel coating. Biomaterials 2008;29:963-9.
34. Balazs DJ, Triandafillu K, Wood P, Chevolot Y, van Delben C, Harms H, et al. Inhibition of bacterial adhesion on PVC endotracheal tubes by RF-oxygen glow discharge, sodium hydroxide and silver nitrate treatments. Biomaterials 2004;25:2139-51.
35. Melaiye A, Youngs WJ. Silver and its application as an antimicrobial agent. Expert Opin Ther Pat 2005;15:125-30.
36. Weir E, Lawlor A, Whelan A, Regan F. The use of nanoparticles in anti-microbial materials and their characterization. Analyst 2008;133:835-45.
37. Hetrick EM, Schoenfisch MH. Reducing implant-related infections: Active release strategies. Chem Soc Rev 2006;35:780-9.
38. Panácek A, Kvítek L, Prucek R, Kolár M, Vecerová R, Pizúrová N, et al. Silver colloid nanoparticles: Synthesis, characterization, and their antibacterial activity. J Phys Chem B 2006;110:16248-53.
39. Kawahara K, Tsuruda K, Morishita M, Uchida M. Antibacterial effect of silver-zeolite on oral bacteria under anaerobic conditions. Dent Mater 2000;16:452-5.
40. Matsuura T, Abe Y, Sato Y, Okamoto K, Ueshige M, Akagawa Y. Prolonged antimicrobial effect of tissue conditioners containing silver-zeolite. J Dent 1997;25:373-7.
41. Damm C, Münstedt H, Rösch A. The antimicrobial efficacy of polyamide 6/silvernano-and microcomposites. Mater Chem Phys 2008;108:61-6.
42. Spadaro JA, Becker RO. Some specific cellular effects of electrically injected silver and gold ions. Bioelectrochem Bioenerg 1975;3:49-57.
43. Duran N, Marcarto PD, De Souza GIH, Alves OL, Esposito E. Antibacterial effects of silver nanoparticles produced by fungal process on textile fabrics and their treatment. J Biomed Nanotechnol 2007;3:203-8.
44. Butkus MA, Edling L, Labare MP. The efficacy of silver as a bactericidal agent: Advantages, limitations and considerations for future use. J Water Supply Res Technol AQUA 2003;52:407-16.
45. Cho KH, Park JE, Osaka T, Park SG. The study of antimicrobial activity and preservative effects of nanosilver ingredient. Electrochim Acta 2005;51:956-60.
46. Feng QL, Wu J, Chen GQ, Cui FZ, Kim TN, Kim JO. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res 2000;52:662-8.
47. Kim JS, Kuk E, Yu KN, Kim JH, Park SJ, Lee HJ, et al. Antimicrobial effects of silver nanoparticles. Nanomedicine 2007;3:95-101.
48. Lok CN, Ho CM, Chen R, He QY, Yu WY, Sun H, et al. Silver nanoparticles: Partial oxidation and antibacterial activities. J Biol Inorg Chem 2007;12:527-34.
49. Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JB, Ramírez JT, et al. The bactericidal effect of silver nanoparticles. Nanotechnology 2005;16:2346-53.
50. Pal S, Tak YK, Song JM. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium Escherichia coli. Appl Environ Microbiol 2007;73:1712-20.
51. Raffi M, Hussain F, Bhatti TM, Akhter JI, Hameed A, Hasan MM. Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224. J Mater Sci Technol 2008;24:192-6.
52. Sondi I, Salopek-Sondi B. Silver nanoparticles as antimicrobial agent: A case study of E. coli as a model for gram-negative bacteria. J Colloid Interface Sci 2004;275:177-82.
53. Kong H, Jang J. Antibacterial properties of novel poly (methyl methacrylate) nanofiber containing silver nanoparticles. Langmuir 2008;24:2051-6.
54. Ahn SJ, Lee SJ, Kook JK, Lim BS. Experimental antimicrobial orthodontic adhesives using nanofillers and silver nanoparticles. Dent Mater 2009;25:206-13.
55. Jain J, Arora S, Rajwade JM, Omray P, Khandelwal S, Paknikar KM. Silver nanoparticles in therapeutics: Development of an antimicrobial gel formulation for topical use. Mol Pharm 2009;6:1388-401.
56. Hernandez-Sierra JF, Ruiz F, Pena D, Martinez-Gutierrez F, Martinez AE, Guillen Ade J, et al. The antimicrobial sensitivity of Streptococcus mutans to nanoparticles of silver, zinc oxide, and gold. Nanomedicine 2008;4:237-40.
57. Hernandez-Sierra JF, Salas-Lopez EK, Martinez-Gutierrez F, Ruíz F, Pierdant-Perez M, Mandeville P, et al. Bactericidal capacity of silver nanoparticles associated with Gantrez S-97 on Streptococcus mutans. J Clin Pediatr Dent 2010;35:183-5.
58. Espinosa-Cristobal LF, Martinez-Castanon GA, Martinez-Martinez RE, Loyola-Rodriguez JP, Patino-Marin N, Reyes-Macias JF, et al. Antibacterial effects of silver nanoparticles against Streptococcus mutans. Mater Lett 2009; 63:2603-6.
59. Kim YS, Kim JS, Cho HS, Rha DS, Kim JM, Park JD et al. Twenty eight day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in sprague-dawley rats. Inhal Toxicol 2008;20:575-83.
60. Hernandez-Sierra JF, Galicia-Cruz O, Salinas-Acosta A, Ruíz F, Pierdant-Perez M, Pozos-Guillen AJ. In vitro cytotoxicity of silver nanoparticles on Human periodontal fibroblasts. J Clin Pediatr Dent 2011;36:37-41.